Transurethral resection of 1250 bladder tumours
- 1 January 1992
- journal article
- Published by Springer Science and Business Media LLC in International Urology and Nephrology
- Vol. 24 (1), 35-42
- https://doi.org/10.1007/bf02552115
Abstract
A total of 1250 bladder tumours were subjected to transurethral resection (891 curative, 107 palliative operations, 252 TUR biopsies). Complication rate was 9.9%, mortality rate 0.8%. In patients with primary tumours the 1-year recurrence rate after TUR was 23.8%, the 3-year rate was 36.6%, with an increase in proportion to stage. The 5-year survival rate was 66.5%. Within five years 9% of the patients died from tumour generalization, also with a rising tendency in proportion to stage. TUR as a curative method is suitable mainly for the removal of Ta and T1, under circumstances also of T2 G1–G2 tumours.Keywords
This publication has 6 references indexed in Scilit:
- Local BCG therapy of superficial bladder tumoursInternational Urology and Nephrology, 1991
- Local adriamycin treatment for prevention of recurrence of superficial bladder tumoursInternational Urology and Nephrology, 1988
- Invasive Bladder Cancer: Tumor Configuration, Lymphatic Invasion and SurvivalJournal of Urology, 1983
- Management of Invasive Bladder Cancer: A Meticulous Pelvic Node Dissection Can Make a DifferenceJournal of Urology, 1982
- Treatment of T3 Bladder Cancer: Controlled Trial of Pre-operative Radiotherapy and Radical Cystectomy Versus Radical Radiotherapy: Second Report and Review (for the Clinical Trials Group, Institute of Urology)British Journal of Urology, 1982
- Regional Lymph Node Metastasis From Bladder CancerJournal of Urology, 1981